Drug recall D-0550-2023
Product
Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52
Reason for recall
CGMP Deviations
Lots and codes
Lot#: F107752201, Exp. Date 05/31/2024
Recall details
- Recalling firm
- Northwind Pharmaceuticals LLC, Indianapolis, IN
- Quantity
- 33 bottles
- Distribution
- Nationwide with the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 16, 2023
Related products
- Doxazosin – drug information
- NDC 51655-109 Doxazosin · Doxazosin Mesylate 4 mg/1 · Northwind Health Company, LLC